• AAPL 169.6
  • TSLA 168.87
  • AMZN 179.57
  • MSFT 409.0099
  • INTC 31.715
  • EURUSD 1.0701
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. IL /
  3. 0MGB.IL

Genmab A/S (0MGB IL) stock market data APIs

kr1965 0(0%) as of April 26, 2024

Genmab A/S Financial Data Overview

1965
1965
-
1973
1965
1824.5-2936
156 637 M
27.6388
65 313 K
16 366 M
9.6747
0.6444
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '0MGB',
Type: 'Common Stock',
Name: 'Genmab A/S',
Exchange: 'IL',
CurrencyCode: 'DKK',
CurrencyName: 'Danish krone',
CurrencySymbol: 'kr',
CountryName: 'UK',
CountryISO: 'GB',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Genmab A/S Fundamental Data is available in our Financial Data APIs

  • Net Revenue 16 366 M
  • EBITDA 6 930 M
  • Earnings Per Share 70.77
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Genmab A/S Earnings via APIs

  • Latest Release 2023-12-31
  • EPS/Forecast NaN

Get Genmab A/S End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Genmab A/S latest news via APIs

Transactions in Connection with Share Buy-back Program Genmab

Genmab A/S Company Announcement COPENHAGEN, Denmark; April 22, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to ...

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024

Genmab A/S Company Announcement Net sales of DARZALEX® in the first quarter of 2024 totaled USD 2,692 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) ...
Do you have any questions?
support@eodhistoricaldata.com